Safety and Tolerability of Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) - a Pilot Study

NCT07660107 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability

Interventions

DIETARY_SUPPLEMENT: Heat-killed Mycolicibacterium petrae KGA-10 (NeuroAlly)
DIETARY_SUPPLEMENT: Placebo (microcrystalline cellulose)

Sponsor

Kioga Inc.

Collaborators

[object Object]